Requests for abortion pills saw a 109 percent increase between June 24 and July 15, nonprofit organization Just the Pill told Becker's. 

As omicron subvariant BA.5 prompts a summer surge in COVID-19 cases, here are two recent studies on vaccine effectiveness against the quickly spreading variant:

The effort to vaccinate children younger than 5 has crawled since its infancy, with CDC data showing less than 3 percent of the nation's 19 million children in this age group with at least one vaccine jab. 

As physicians balance patient care in the turmoil following the Supreme Court's decision to reverse Roe v. Wade, the pharmaceutical industry has been hit on multiple fronts, and CVS Health is the latest retail chain to add another step in its pharmacy practices. 

The Biden administration is pushing for vaccine-makers to tweak their vaccines for better efficacy against omicron subvariants BA.4 and BA.5 while suppressing efforts to deploy a second booster to adults younger than 50, The Washington Post reported July 22. 

For months, legislators have chipped away at President Joe Biden's Build Back Better Act, with the resulting leftovers centering around lowering drug costs for Medicare and Medicaid beneficiaries, according to The Washington Post.

About four weeks after the Supreme Court reversed the national right to an abortion, the House passed legislation July 21 to secure the right to contraceptives, according to CNBC. 

When the FDA declared pharmacists could prescribe Pfizer's antiviral treatment directly to patients in early July, it caused a flurry of mixed reactions among the healthcare industry. The widespread staffing shortage could be halting the process, though. 

As the World Health Organization continues its rollout of the first authorized malaria vaccine, one of the key investors has pulled out because of the vaccine's low efficacy, according to The Washington Post.

Now that Novavax has entered the COVID-19 vaccine scene, here's a rundown of the similarities and differences among each vaccine option, according to Yale Medicine:

After more than a year of Pfizer, Moderna and Johnson & Johnson shots going into people's arms, there's now a fourth vaccine option. 

The executive vice president and general counsel of Johnson & Johnson, Michael Ullman, MD, plans to retire by the end of 2022 and will be succeeded by Elizabeth Forminard, effective Oct. 17.

The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.

The hashtag "BoycottWalgreens" has flooded social media after a customer took to Twitter earlier this month, alleging a Walgreens worker refused to sell condoms because of religious reasons. 

The FDA granted Incyte, a Wilmington, Del.-based pharmaceutical company, the first approval for a vitiligo treatment after finding positive results in its phase 3 trials July 18. 

An online pharmacy that isn't yet a year old introduced a new option for its customers July 18: Pay $10 a month for an unlimited number of prescriptions. 

Though Novavax's COVID-19 vaccine candidate could appeal to those wary of mRNA-based vaccines, don't expect it to spur that much change, health experts told CNBC July 15. 

Some pharmacists have been more cautious about filling prescriptions as legal concerns rise for healthcare workers offering reproductive care since the U.S. Supreme Court overturned Roe v. Wade, the Dallas Morning News reported July 18. 

As parents hesitate to inoculate their youngest children and some states are ordering fewer COVID-19 vaccine doses, health experts expressed worry about low vaccination rates, Politico reported July 14. 

Vancomycin, an antibiotic medication used to treat serious bacterial infections, can lead to increased nephrotoxicity without improved efficacy if administered in an excessive dosage, or can fail to achieve the desired therapeutic effect if underdosed.